|This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.|
Considering that the US FDA has just 'approved' fecal transplants, a potentially revolutionary therapy, it is wrong to label an article on Tom Borody, who is a pioneer in this area, as being of "low importance." Additionally, to say that this is a "Start-Class" is misleading, as it really carries sufficient information to define the individual's notability at this point in time, IMO Trevmar (talk) 17:34, 5 November 2013 (UTC)
Multiple issues, mainly failure to reference.Edit
This article contains controversial claims and gives credit to the subject for work that other people are credited with in authoritative sources, these claims lack any references beyond the subject's personal website. For instance while he was a co-author on papers describing triple therapy he was neither first author nor senior author, yet the article says "is considered to be the first physician to successfully formulate the triple therapy". The language also obviously falls within scope of "weasel words".
I have deleted the unreferenced statements except the bit on fecal transplant, I found a lancet RCT with him as senior author, so have retained that statement and referenced.'
Deleted his current private practice details as they are not in any way linked to notability and read simply as advertising. — Preceding unsigned comment added by 22.214.171.124 (talk) 07:24, 12 August 2020 (UTC)